Upgrade to SI Premium - Free Trial

Moderna (MRNA)

242.08 +15.19 (6.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26)

Latest Headlines

Moderna shares rise ahead of cancer vaccine trial results October 19, 2026 9:50 AM - StreetInsider U.S. biotech SMids: Q3 earnings preview October 18, 2026 8:00 PM - StreetInsider Form 4 Moderna, Inc. For: Oct 14 Filed by: Hoge Stephen October 16, 2026 4:09 PM - SEC Filing RBC: 'ESMO is likely the biggest event for MRK/MRNA for the rest of this year' October 16, 2026 10:51 AM - StreetInsider Moderna shares fall amid valuation concerns October 16, 2026 10:02 AM - StreetInsider Form 144 Moderna, Inc. Filed by: Hoge Stephen October 15, 2026 10:32 AM - SEC Filing Moderna (MRNA) PT Raised to $137 at Goldman Sachs October 15, 2026 7:15 AM - StreetInsider Form 144 Moderna, Inc. Filed by: Hoge Stephen October 14, 2026 9:59 AM - SEC Filing AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test October 14, 2026 9:45 AM - StreetInsider Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026 October 13, 2026 7:03 AM - StreetInsider Form 4 Moderna, Inc. For: Oct 05 Filed by: Mock James M October 7, 2026 4:05 PM - SEC Filing 2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope October 7, 2026 10:00 AM - StreetInsider Tempus expands collaboration with Moderna and Merck on cancer therapy October 7, 2026 8:31 AM - StreetInsider Moderna (MRNA) PT Raised to $95 at Morgan Stanley October 7, 2026 7:58 AM - StreetInsider Novavax and Moderna shares fall after plague concerns ease, Citi comments October 7, 2026 5:06 AM - StreetInsider Form 3 Moderna, Inc. For: Oct 05 Filed by: Andres Juan October 5, 2026 6:27 PM - SEC Filing Moderna to join the Nasdaq-100 index, replacing Warner Bros. Discovery October 2, 2026 6:04 AM - StreetInsider Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 October 1, 2026 8:00 PM - StreetInsider Moderna (MRNA) call put ratio 1 call to 1.1 puts amid wide price movement September 30, 2026 11:10 AM - StreetInsider Premarket movers: Micron; Boeing rises, Moderna slides September 30, 2026 7:43 AM - StreetInsider Form 8-K Moderna, Inc. For: Sep 30 September 30, 2026 7:15 AM - SEC Filing Moderna: Citi says oncology optimism is priced in, cuts rating to sell September 30, 2026 7:11 AM - StreetInsider Moderna names Juan Andres as COO amid oncology expansion September 30, 2026 7:01 AM - StreetInsider Moderna Adds Chief Operating Officer Role as Company Expands into Oncology September 30, 2026 7:01 AM - StreetInsider Moderna (MRNA) call put ratio 1.4 calls to 1 put into share price lower before the bell September 30, 2026 6:01 AM - StreetInsider Citi downgrades Moderna to Sell, sets $80 price target September 30, 2026 5:01 AM - StreetInsider Bernstein SocGen Reiterates Market Perform Rating on Moderna (MRNA) September 25, 2026 8:09 AM - StreetInsider UBS Reiterates Neutral Rating on Moderna (MRNA) September 22, 2026 9:25 AM - StreetInsider Moderna to present mRNA cancer therapy data at ESMO 2026 September 21, 2026 10:13 AM - StreetInsider Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026 September 21, 2026 10:13 AM - StreetInsider Moderna shares climb on cancer vaccine momentum September 21, 2026 10:06 AM - StreetInsider Moderna (MRNA) spreader of 1K contracts of September 25 weekly 157.50 and 165 calls as share price up 10.5% September 17, 2026 10:30 AM - StreetInsider Moderna shares gain on momentum and short squeeze September 17, 2026 10:10 AM - StreetInsider Form 4 Moderna, Inc. For: Sep 14 Filed by: Hoge Stephen September 16, 2026 4:48 PM - SEC Filing Form 144 Moderna, Inc. Filed by: Hoge Stephen September 15, 2026 10:46 AM - SEC Filing A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat September 15, 2026 9:00 AM - StreetInsider Form 4 Moderna, Inc. For: Sep 10 Filed by: Mock James M September 14, 2026 4:25 PM - SEC Filing Form 144 Moderna, Inc. Filed by: Hoge Stephen September 14, 2026 2:40 PM - SEC Filing Form 144 Moderna, Inc. Filed by: Mock James M September 10, 2026 10:15 AM - SEC Filing Rothschild Redburn Downgrades Moderna (MRNA) to Sell September 3, 2026 2:31 AM - StreetInsider Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26' September 1, 2026 9:07 AM - StreetInsider Moderna to Present at Upcoming Conferences in September 2026 September 1, 2026 7:01 AM - StreetInsider BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast August 28, 2026 9:46 AM - StreetInsider Argus Upgrades Moderna (MRNA) to Buy August 28, 2026 7:19 AM - StreetInsider Moderna prices $2.6B convertible notes offering due 2032 August 28, 2026 7:00 AM - StreetInsider Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes August 28, 2026 7:00 AM - StreetInsider FDA approves Moderna's updated 2026-2027 COVID-19 vaccines August 27, 2026 3:58 PM - StreetInsider Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines August 27, 2026 3:58 PM - StreetInsider Moderna plans $2B convertible notes offering due 2032 August 27, 2026 7:21 AM - StreetInsider Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes August 27, 2026 7:21 AM - StreetInsider A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity August 26, 2026 9:20 AM - StreetInsider Wolfe Research Upgrades Moderna (MRNA) to Peerperform August 25, 2026 5:31 AM - StreetInsider Moderna (MRNA) PT Raised to $125 at Barclays August 25, 2026 4:08 AM - StreetInsider Active options: MRNA SOFI BABA INTC MARA META COIN AMD GOOGL MSFT WMT August 24, 2026 5:25 AM - StreetInsider Moderna (MRNA) call put ratio 1.1 calls to 1 put amid sharp rally August 24, 2026 5:21 AM - StreetInsider Moderna (MRNA) PT Raised to $77 at JPMorgan August 21, 2026 9:28 AM - StreetInsider BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough August 20, 2026 7:23 AM - StreetInsider Moderna stock pulls back after massive one-day rally: analysts weigh in August 20, 2026 7:23 AM - StreetInsider Moderna (MRNA) PT Raised to $150 at UBS August 20, 2026 6:55 AM - StreetInsider Guggenheim Reiterates Buy Rating on Merck (MRK) August 20, 2026 6:47 AM - StreetInsider Moderna (MRNA) PT Raised to $120 at Goldman Sachs August 20, 2026 6:43 AM - StreetInsider Moderna (MRNA) call put ratio 1 calls to 2.1 puts amid wide price movement August 20, 2026 4:51 AM - StreetInsider Moderna (MRNA) PT Raised to $89 at Morgan Stanley August 19, 2026 4:23 PM - StreetInsider Morgan Stanley Upgrades Merck (MRK) to Overweight August 19, 2026 4:22 PM - StreetInsider Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN August 19, 2026 3:11 PM - StreetInsider BofA Securities Upgrades Moderna (MRNA) to Neutral August 19, 2026 1:40 PM - StreetInsider Moderna short sellers face $4.8 billion loss amid record stock jump August 19, 2026 11:31 AM - StreetInsider Moderna (MRNA) call put ratio 1 calls to 1.9 puts after INTerpath-001 trial results August 19, 2026 11:21 AM - StreetInsider Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA) Following Positive Intismeran Data August 19, 2026 9:34 AM - StreetInsider Stocks expected to have increasing option volume: MRNA RGEN DHR TMO MRVI SKHY August 19, 2026 9:18 AM - StreetInsider Moderna (MRNA) call put ratio 2.1 calls to 1 put into INTerpath-001 trial results August 19, 2026 9:11 AM - StreetInsider William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business August 19, 2026 8:11 AM - StreetInsider Moderna shares soar on melanoma drug trial success August 19, 2026 7:03 AM - StreetInsider Merck and Moderna's melanoma drug combo beats Keytruda alone in trial August 19, 2026 6:45 AM - StreetInsider Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients Wi August 19, 2026 6:45 AM - BizWire Form SCHEDULE 13G Moderna, Inc. Filed by: Capital World Investors August 12, 2026 5:41 PM - SEC Filing Form 4 Moderna, Inc. For: Aug 05 Filed by: Bancel Stephane August 7, 2026 4:12 PM - SEC Filing Trump Administration Weighs Order On Autism And Vaccines - Bloomberg August 6, 2026 4:36 PM - StreetInsider Form SCHEDULE 13G/A Moderna, Inc. Filed by: FMR LLC August 6, 2026 10:36 AM - SEC Filing Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) Following FDA Approval of mRNA Flu Vaccine August 6, 2026 8:42 AM - StreetInsider FDA approves Moderna's mRNA influenza vaccine for adults 50 and older August 5, 2026 10:15 PM - StreetInsider Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA August 5, 2026 10:15 PM - StreetInsider Form 144 Moderna, Inc. Filed by: Bancel Stephane August 5, 2026 1:02 PM - SEC Filing Moderna begins Phase 1 trial of Bundibugyo ebolavirus vaccine August 4, 2026 11:01 AM - StreetInsider Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus August 4, 2026 11:01 AM - StreetInsider Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) August 3, 2026 10:05 AM - StreetInsider U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage August 1, 2026 10:00 AM - StreetInsider Form 10-Q Moderna, Inc. For: Jun 30 July 31, 2026 4:18 PM - SEC Filing Form 8-K Moderna, Inc. For: Jul 31 July 31, 2026 7:04 AM - SEC Filing Moderna (MRNA) Tops Q2 EPS by 6c, Beats on Revenue July 31, 2026 7:01 AM - StreetInsider Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates July 31, 2026 7:01 AM - StreetInsider Form SCHEDULE 13G/A Moderna, Inc. Filed by: BAILLIE GIFFORD & CO July 24, 2026 10:11 AM - SEC Filing Full Article List